David Elkins

David Elkins

Director of Finance/CFO at BRISTOL-MYERS SQUIBB COMPANY

Net worth: 10 M $ as of 31/05/2026

58 year
Health Technology
Consumer Services
Electronic Technology

Profile

Currently, David V. Elkins is Chief Financial Officer & Executive Vice President of Bristol Myers Squibb Co. and CFO, Principal Accounting Officer & Executive VP at Celgene Corp. (a subsidiary of Bristol Myers Squibb Co.). Mr. Elkins previously was Chief Financial Officer & Executive Vice President for Becton, Dickinson & Co., Chief Financial Officer for Round Rock Research LLC, Principal at The Boeing Co., CFO-Consumer Products, Medical Devices & Functions at Johnson & Johnson, Chief Financial Officer for AstraZeneca Plc and Chief Financial Officer & Vice President for AstraZeneca Pharmaceuticals LP (a subsidiary of AstraZeneca Plc) and Director-Corporate Strategy & Development at Unisys Ltd. He received an undergraduate degree from the University of Delaware, an MBA from Drexel University and a graduate degree from the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/04/2026 159,542 ( 0.01% ) 9 M $ 31/05/2026
13/11/2025 7,347 ( 0% ) 1 M $ 31/05/2026

David Elkins active positions

CompaniesPositionStart
BRISTOL-MYERS SQUIBB COMPANY Director of Finance/CFO 20/11/2019
TAPESTRY, INC. Director/Board Member 29/02/2024

Former positions of David Elkins

CompaniesPositionEnd
JOHNSON & JOHNSON Corporate Officer/Principal 01/06/2018
Director of Finance/CFO 01/09/2014
BECTON, DICKINSON AND COMPANY Director of Finance/CFO 07/11/2012
Director of Finance/CFO 01/12/2008
ASTRAZENECA PLC Corporate Officer/Principal 01/12/2008
See the detail of David Elkins's experience

Training of David Elkins

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

79

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Electronic Technology

Health Technology

Health Technology

Health Technology

Health Technology

Retail Trade

Consumer Services

Commercial Services

Consumer Services

Consumer Services

Health Technology

Consumer Services

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!